Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gold, I truly hope you and we receive a string of accurate honest responses.. maybe from PL or Marv or ( don't count on it)the company.
Yes, it was KITE and the posting inference was a like or surprising value.
Maybe there remains the possibility.
However, the current sub, sub basement MC @ 1% is the current reality. You can't cash in " Hope." You rely on the management, and others comment on that.
Oh, my error, the market cap is not $329 million, rather is $128... that would be 1% of what the " cheerleaders" claimed only a year ago... 1%...
A tough action.. so many feel the same way... now a micro, micro market cap of $329 million... a year ago.. boasts were made that this should be will be a $12 billion dollar value. Either many were " nuts" then, or we are subject to " nuts now, or.... let's be honest, the ' wise' market says.. nothing to see, nothing to cause buying of Marker.
The science is in the hands of others, not us. Management is in the mode of funding, spending , and keeping quiet.
What a massive change from 3.. 2. or a year ago.. 70% off the high.. you happy?
Actually P/L, I do accept your refreshing of the facts.... in this case.
Perhaps a review of what MRKR has control over and which there are marketing and distribution licenses would be helpful. Thoughts?
PII trial with 480 recruitment patients is beginning, and the company does not issue a PR? Continuously, I am criticized for asking the company to conform to PR as the vast majority of public companies do, to comply with Reg. FD, to inform investor owners( yes.. I am an owner of this company), and to present the positives and future outlook to any interested public.
Certainly, I support the science and trials. I will not agree with those who by word posts suggest not to ask questions.
I have been here for years and in the past sa few posters had legitimate communications with PH and posted here... but.. apparently no more.. why? Has the internal culture shifted, closed in?
Please,I would appreciate honest responses rather than acerbic stifling.
Lastly, the share price and market cap is crazy... look back at the history and rationalize the how reflecting on the percieved greater progress made quarter over quarter.
PL... I'm not isolated on some south Pacific island... putting aside my last two posts, which one simply pointed out that FATE and other bios release IR updates on a variety of corporate findings. The other raising the question of effective IR actions whether in a lack of updates and responses to inquires rather than being ignored.. very reasonable.
Even you can't tell me that content given to the investment conference and the science conference .... had no new and good data... if not, there was no reason to attend. But, with some interesting interim results, MRKR could have, should have put out an update, if for no other reason than to say ' yes, we're still alive.' I can not agree with your reluctance and I wonder if you communicate with PH and anywhere's the frequency as months and years earlier.
Look at FATE on yahoo...
2 things to comment on.
..1) Fate communicates! This P/R was in a phase 1 study... communication.
.. 2) I would hope that our MRKR interacts with them... a good combo of treatment and maintenance.
Have a good day.
Tom. I read your thoughts ... the closing bell just rang ending a week with 2 presentations, not the usual quiet as a tomb endurance.
Just noting that JNCE,SRNE, SCMO, and FATE are up... and have been going up.
MRKR... closed down.
Some causes.. a crummy IR contract and no one cares, buyers of this biomed are not impressed, partners are not interested.
If the science is in fact good, then communication is ineffective. No excuses.
Adding to my prior post, I track ( but do not own) JNCE, SRNE,SGMO, FATE.. only for price action compared to MRKR which I have has great hopes..
Business communications wise, there is a failure within the company and the Investors Relations function to Press Release information and results data.
There were two presentations early this week, one investors, the other scientific.
A few posters claim to be overwhelmed at a variety of " great data" CR's and progress.
Yet here we are, Friday morning, November jobs report is above expectations, unemployment rate 3.5%, best in 50 years, the markets move sharply up.. and MARKER? The needle barely budged. Why?
Skip the new buy in breed of " cheer leaders" posts, and get down to business. Answering the " Why" including from a 3 year regressive S/P. Including S/P action of like kind Bio stocks FATE,JUNO and add your favotites.
3 years ago, posters pumped ' break through coming in 1 or 2 years. Now years later, wait another 2 - 3 years.. TPIV once once the golden egg among with Polystart, now either on back burner or off the stove. Now differing opinions between CAR-T and Multi science.. what's with these and a reliable future.
.... summary point.. what will it take, after looking at past recent presentations to move the needle to a reasonable Market Cap?
I think I am being reasonable in asking honest investor questions.. maybe you do too.
Almost 2:00 PM.. Piper seance must be over..stock dropping, volume increasing.. I' ve been right and wrong.. Right in demanding IR releases.. wrong on believing in this management and as a result losing nearly 4 years, reverse splits, and an unrecoverable loss of cash...
Blue and PL.. what have you to say? How are the communications with Peter?
A rookie CEO who was resume puffed up.
Maybe some honest posters will chime in.
Marv..70,000 here with Ave @ $6.83.. and yet another down day. The markets are in fact viewing the company at present as a loser of an investment.
I don't care about the " cheerleaders posts... the share price tells the story.
I just want to get out, and had hoped for a return near break even... awaiting the FDA response and some positive remarks from the company.
I got in because of TPIV years ago, endured 2 reverse splits, and stayed because my sister has CML... I've paid a price on many levels. Let's get honest.
Keith.. you a Mn. MIC fellow?
Pl, my friend. We have for a long time. Ow either agreed on items or respectfully disagreed, always in a healthy manner and always seeking the best outcome.
To the point, no, I don't think 2 or 3 times a year is sufficient. On the contrary, other bio tech companies do communicate issues and successes more frequently.
We have been taken down from a high of ~ $9.00 to where we are because of mistakes by management. A management with brilliant scientific knowledge, skills, and connections. Two departments are weak... Law, and Finance with HR. External communications are a part of and prepared by them. My opinion. Market reflection.
PL and others, I don't think this off remark of data fabrication is taken seriously by any or by a few. Let's let that one die off.
What is of concern is whether the company cares enough of the owner shareholders to establish messaging that is powerful enough to increase share price or at least to update what progress is.being made.. twice a year is not acceptable, four times a year is a meager offering.
What also concerns investors is time lines by like kind of research by current or developing competitors. That is to say... arriving late to the party,or to the altar, or phrase it anyway you want. Thoughts?
For the record..Nov. 13.. 30 minutes of opening trades..$2.92.. -$1.00...-26%..604,000 shares traded..
Cumulative loss $322 million.
Authorized shares outstanding 45 million.
Loss per share $7.10...
Cash on hand $48 million..
.... Find a buyer for $7.20 per share and let the shareholders vote. My bet would be..a majority of shareholders would take the opportunity to get out.
The science thus far is not compelling and the CEO is not capable of increasing shareholder value... look at the slide from $9.00+ to where we are today at this time..$3.50...
I'm tired of self serving cheerleaders.
Reg.FD is in question regarding events during this past quarter.
All IMO.. you decide for yourself.
MRKR cancelled the Ovarian clinical research and trials. How much was the total associated costs and were these written off and reflected in the third quarter 2019 financials and footnoted?
Research... the TPIV ovarian cancer trial.. failed... waiting to read of the pthers.. check to see if I am wrong..
Having lost most of retirement, I am legitimately " honked off."
Worst case, in my mind, the share price slowly falls below $1.00... up against the wall to raise capital... run us little guys off the reservation... big pharma buys at $1.50.. bonuses for and retention of management. Think it can't happen? It has before... oh, add in law suits to begin very soon.
I should have known... another PoS.
I guess TPIV trials have failed. Why did only shorts know this? Pre market down .40 and tomorrow isn't here yet.
Time to cut dead wood, reduce expenses, conserve cash, and put P.H. on a short leash... no excuses will satisfy a failed 2019..
Where is the presentation and update for all the TPIV and Polystart clinical trials and future.. that article suggesting 2014 is rediculous.
PL ,Mac. And others... you need to get behind the curtain and find out what the heck reall is going on.. I have no trust in this massive management group, paid well, doing very little.
Do they play cribbage or board games most days?
Scary... price fading.. shouldn't be this way.. two more hours and there better be somethings to hold on to...
Tomorrow is the first and last time to present its story for 2019 in a solid and positive way. Present the current pipeline. Present where we are in clinical trials. Present a forward look and best timing. Present the scope of moving forward with the FDA. Present any partnership or purchase inquiries. Present any legal concerns, capital requirements, and risk.
Make it strong for investors and capital markets. Lastly, comment on the strengths of the current management team.
GLTA... GLTM.
There is a reporting date requirement for.public companies.... 45 days from a quarter end.. Up front companies issue an advanced notice of the release and conference date. Who needs excuses of " we don't don't do it that way?
As much as I would like to fake it, I don't have a good feeling about where the company is at.
Oh, how I wish that I am so very wrong.
Company reporting is the only real answer. Here we are Friday and nothing up to this minute..
Opening @ $4.05... Yahoo says Monday is earnings call... No confirmation by MRKR.
I realize that on this board that I am in the very small minority that believes that this company should communicate like other companies... I look at FATE as an example and could list other biotechs... I now also realize that the company only has distribution rights while funding third party research yet not having any control over clinical progress... result.. a captive position.
Should MRKR have a financial and clinical update that is positive, we climb maybe to a lofty $7.00. If the opposite, a new low will take place and what happens with regard to future multi million capital needs??? I'm unsure and uneasy.. the majority of you are supportive of the company operations as is... I don't like " hope" as a word for business, rather successful execution. Very disappointed in management communications at all levels.
P.L. as you know from the years, I have great regard for your thoughts and I assume that my biz/ investment thoughts are of value also.
When the company decides to issue two update calls/ releases it has to weigh other realities.. such as.. what is the frequency of other like kind biotechs?
IMO, at this low S/P, with this stance, it might prove difficult to hold retail investors and to attract new ones. This might portend a weak share price especially in light of near term additional capital needs and dilution.
I understand the company decision making, but have concerns....
Thanks for the healthy dialogue.
P.L.to that point, not much going on, we are all in agreement. We have no choice but to painfully wait and wait.
I just don't understand the employing of high priced and knowledgeable management talent covering all business, clinical, and governmental areas... and not have progress news.. do you? Does anyone?
Like many others here, I trust you will remain here and as a shareholder.
If this and other M/ boards have gone[
"down hill"... and they have because of frustration and losses.... wouldn't it be better and wiser to continue to share and opine? With respect " taking your ball and bat home " isn't the best action in my ooinion.... P.L. think it over..
Well.... at $3.76, MRKR is 60% off the $9.90.high and down 25% in this month.
Sellers are active, but to get a buyer, the price has to drop. A lack of demand.
At market cap of $180 million, it is like a slap in the face when 6+ months ago, posters were suggesting a MC of $2 billion based on known company comparables.
It seems like on or near November 12 the 3rd results will be coming... I would advise management, P.H., that if not before, then there needs to be a long and detailed management D & A.
Unless there is widespread failure within all the C/ trials, none of this makes sense.
Management must be concerned about shareholders wealth improvement... but as in the past I have said this until I was blue in the face.
We're getting investment killed.
P.L..... you do communicate with management and later have added to this board.
A change of heart? Still holding 100%?
Sorry folks.. just me with a slow financial death over here on the corner.
PL..why is this MB minimizing the work put into TPIV 110 AND 200 and polystart?
Breast cancer month (today is 23rd)is now and the company has nothing to offer, nothing to say?
The company and this MB had a new PC toy to play with?
PL months ago, years ago, you had a strong voice, spoke with P.H. and others.. what has happened? We're in the ' dumper. Like a few others, down hundreds of thousands of dollars, none are wealthy, but going back 5+ years, it seems like the story has dramatically weakened, cash outflows have HR increased, and where are we?
...no one gives a definitive answer.. rather gibberish on " buy outs", and wishful thinking.
Let me be clear... Peter is way past due in effective communications... honestly, it feels like things have already gone south, but not being honest. We broke below $4.00 today. In two words.. the first begins with a capital "B"..
I can't get any answer from them.
I can't be the only one here who understands the business/ investor side of this lax happening..? Or, am I???
Respectfully, and with great wishes for your continued remission, might I be bold to respond... many of us are aware of Houstons prestigious medical centers. Thanks for the area size and number of enoloyees... How ever, with regards to MRKR, al you said was that certain doctors you interact with "are aware of the clinical trials..." So are hundreds of others across the land, but that is all that there is.. awareness..
Wouldn't you be more secure if you read reports from the company itself?
Stay well and may your life be filled with peace and joy.
At $4.10, a micro, micro $187 million dollar Market cap... oh my.. a big pharma could buy it with change that falls from their pants into the couch.
At 5 times current price or a $1 billion offered... how many do you think would jump at it through sell trades? 1 year+ ago, excited posters here were projecting $12 billion. Evaporated thinking and wishing.
I wouldn't be negative if I read any data. Don't ignore my words , but forgive my cynicism, which has built up over the past year.
I'd like to see the supporting SEC filings. Are we now headed to below $4.00 and some here think that is tolerable?
On a more positive note, I believe that the company understands Reg. FD..no data fsvoratism based on being significant holders.
On the negative side I think law suits will soon be flying, the losses are huge and the reporting is sparse.
Either the science is faulty and to blame or the company has many licenses, and the expense, but no control, (sic) a captive 'pay out' management and it is to blame for not issuing press releases.
I'd love and faint to be wrong by soon reading a press release and a continuing share price increase..
PL.. I understand you staying safe in the woods, you had contributed greatly.
4cat.. agreed with his good fortune.rarher than my past 5 years.. of losses. Bottom line, no matter the opinions for or against....we are dependent on the realities of the company directly from the company... and it better be soon.
As an aside, salt on open wounds would be to be delisted and back on the penny pinks.
Ccl... good for you a newbie, maybe in at this low S/P. but three points to consider. .
... some loose myself are here for many years.. been through much ' cheerleading' but down multi hundred of thousands. If you were in that group, you wouldn't be as glib.
.... much of you post is ' cheerleading'.
Business and investment is about honest and effective communication of operations. You post seems to be lacking in that.
... the coming dilution in 2020 at this price: $25 mill.. is a 10% dilution before min market reaction.. make that up to 30%. So... " back up your truck... buy 50,000 shares this week... then, calculate the risk/ reward.. and come back and post.
.... What most want here is... a press release of where we honestly are in our shared trials..What the near term and mid term future looks like... and where are we against all the research/ c/ trials competition.
Good luck ( oh, never mind, as that is another empty emotion).
The last and best multi clinical trials report directly from the company to the public was on January 03, 2019.. read it on Yahoo.mb. MRKR..
It was both a good and lengthy presentation and now 10 more months by have passed. I would think that each of us would like to know from all those trials and patients enrolled an updated report from that date and earlier work.
Yes? No? Without useless defending balony?
Meaning a corporate release for the public, not science paper.
Another down day, another kick in the slats...
TPIV began trials in 2017... I think an update now is in order including progress on already granted' Fast track' and Orphan drug' status.
What are the new specialized hires accomplishing?
PC updates...
Any offers to buy out or partner?
PH, a gifted fellow for sure but he works for us, the owners.
Some of you are newbies and welcome to a great science, but a low share price.
Only a few of us have gone through two reverse stock splits.. like me my break even is over $10 a share.. so, yes we few expect the company to issue reports on progress made, future possibilities, what's new and what is difficult.
The company history is one of little communication, the life blood to bios..